These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26080355)

  • 1. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.
    Cox BD; Prosser AR; Katzman BM; Alcaraz AA; Liotta DC; Wilson LJ; Snyder JP
    Chembiochem; 2014 Jul; 15(11):1614-20. PubMed ID: 24990206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction between an allosteric agonist pepducin and the chemokine receptor CXCR4.
    Janz JM; Ren Y; Looby R; Kazmi MA; Sachdev P; Grunbeck A; Haggis L; Chinnapen D; Lin AY; Seibert C; McMurry T; Carlson KE; Muir TW; Hunt S; Sakmar TP
    J Am Chem Soc; 2011 Oct; 133(40):15878-81. PubMed ID: 21905700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists.
    Kawatkar SP; Yan M; Gevariya H; Lim MY; Eisold S; Zhu X; Huang Z; An J
    Exp Biol Med (Maywood); 2011 Jul; 236(7):844-50. PubMed ID: 21697335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hologram quantitative structure activity relationship, docking, and molecular dynamics studies of inhibitors for CXCR4.
    Zhang C; Du C; Feng Z; Zhu J; Li Y
    Chem Biol Drug Des; 2015 Feb; 85(2):119-36. PubMed ID: 24923360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000.
    Deganutti G; Cuzzolin A; Ciancetta A; Moro S
    Bioorg Med Chem; 2015 Jul; 23(14):4065-71. PubMed ID: 25868747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.
    Inan T; Flinko R; Lewis GK; MacKerell AD; Kurkcuoglu O
    J Phys Chem B; 2024 May; 128(21):5157-5174. PubMed ID: 38647430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.
    Wong RS; Bodart V; Metz M; Labrecque J; Bridger G; Fricker SP
    Mol Pharmacol; 2008 Dec; 74(6):1485-95. PubMed ID: 18768385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.
    Mosi RM; Anastassova V; Cox J; Darkes MC; Idzan SR; Labrecque J; Lau G; Nelson KL; Patel K; Santucci Z; Wong RS; Skerlj RT; Bridger GJ; Huskens D; Schols D; Fricker SP
    Biochem Pharmacol; 2012 Feb; 83(4):472-9. PubMed ID: 22146583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
    Hui WQ; Cheng Q; Liu TY; Ouyang Q
    J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.
    Quoyer J; Janz JM; Luo J; Ren Y; Armando S; Lukashova V; Benovic JL; Carlson KE; Hunt SW; Bouvier M
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):E5088-97. PubMed ID: 24309376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.
    Zhang P; Covic L; Kuliopulos A
    Methods Mol Biol; 2015; 1324():191-203. PubMed ID: 26202271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway and mechanism of drug binding to chemokine receptors revealed by accelerated molecular simulations.
    Pawnikar S; Miao Y
    Future Med Chem; 2020 Jul; 12(13):1213-1225. PubMed ID: 32515227
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4.
    Zhu S; Meng Q; Schooley RT; An J; Xu Y; Huang Z
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31412600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
    Cutolo P; Basdevant N; Bernadat G; Bachelerie F; Ha-Duong T
    J Biomol Struct Dyn; 2017 Feb; 35(2):399-412. PubMed ID: 26813575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators.
    Yuan J; Jiang C; Wang J; Chen CJ; Hao Y; Zhao G; Feng Z; Xie XQ
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
    Lam AR; Bhattacharya S; Patel K; Hall SE; Mao A; Vaidehi N
    J Chem Inf Model; 2011 Jan; 51(1):139-47. PubMed ID: 21158459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
    Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
    J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.